Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas

Jennifer M. Boland; Sibel Erdogan; George Vasmatzis; Ping Yang; Lori S. Tillmans; Michele R.Erickson Johnson; Xiaoke Wang; Lisa M. Peterson; Kevin C. Halling; Andre M. Oliveira; Marie Christine Aubry; Eunhee S. Yi

doi:10.1016/j.humpath.2009.01.012

Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas

Jennifer M. Boland, Sibel Erdogan, George Vasmatzis, Ping Yang, Lori S. Tillmans, Michele R.Erickson Johnson, Xiaoke Wang, Lisa M. Peterson, Kevin C. Halling, Andre M. Oliveira, Marie Christine Aubry, Eunhee S. Yi

Research output: Contribution to journal › Article › peer-review

150 Scopus citations

Abstract

Recently, the fusion gene EML4-ALK was identified in non-small cell lung carcinoma, which could be a potential therapeutic target. We investigated the prevalence of anaplastic lymphoma kinase protein expression in these tumors by immunohistochemistry and correlated the results with data from ALK molecular studies. Gene expression profiling was performed on 35 adenocarcinomas to identify cases with ALK gene up-regulation, which was correlated with protein overexpression by immunohistochemistry. Immunohistochemistry was also performed on an independent cohort consisting of 150 adenocarcinomas and 150 squamous cell carcinomas to evaluate the utility of anaplastic lymphoma kinase immunostaining as a screening tool. Florescence in situ hybridization for the ALK locus and reverse transcriptase-polymerase chain reaction for EML4-ALK were performed on tumors positive for anaplastic lymphoma kinase by immunohistochemistry. Transcriptional up-regulation of ALK was identified in 2 (6%) of 35 adenocarcinomas by gene expression profiling. These 2 cases were positive for anaplastic lymphoma kinase by immunohistochemistry, whereas the remaining 33 cases were completely negative. In the independent cohort, anaplastic lymphoma kinase immunostaining was positive in 1 of 150 squamous cell carcinomas and in 3 of 150 adenocarcinomas. The 6 cases positive for anaplastic lymphoma kinase by immunohistochemistry showed evidence of ALK locus rearrangement by florescence in situ hybridization but were negative for EGFR and KRAS mutation. The presence of EML4-ALK fusion transcript was confirmed in 2 cases by reverse transcriptase-polymerase chain reaction. In conclusion, anaplastic lymphoma kinase immunoreactivity in non-small cell lung carcinomas was associated with transcriptional up-regulation, ALK locus rearrangement, and the presence of EML4-ALK fusion transcript. Anaplastic lymphoma kinase immunohistochemistry may have utility as a screening tool or as a surrogate marker for the molecular techniques to detect the EML4-ALK fusion gene in these tumors.

Original language	English (US)
Pages (from-to)	1152-1158
Number of pages	7
Journal	Human Pathology
Volume	40
Issue number	8
DOIs	https://doi.org/10.1016/j.humpath.2009.01.012
State	Published - Aug 2009

Keywords

ALK
EML4-ALK fusion transcript
FISH
NSCLC

ASJC Scopus subject areas

Pathology and Forensic Medicine

Access to Document

10.1016/j.humpath.2009.01.012

Cite this

Boland, J. M., Erdogan, S., Vasmatzis, G., Yang, P., Tillmans, L. S., Johnson, M. R. E., Wang, X., Peterson, L. M., Halling, K. C., Oliveira, A. M., Aubry, M. C., & Yi, E. S. (2009). Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Human Pathology, 40(8), 1152-1158. https://doi.org/10.1016/j.humpath.2009.01.012

Boland, JM, Erdogan, S, Vasmatzis, G , Yang, P, Tillmans, LS, Johnson, MRE, Wang, X, Peterson, LM, Halling, KC, Oliveira, AM, Aubry, MC & Yi, ES 2009, 'Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas', Human Pathology, vol. 40, no. 8, pp. 1152-1158. https://doi.org/10.1016/j.humpath.2009.01.012

@article{673608218a8b49839be2f78a12780b90,

title = "Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas",

abstract = "Recently, the fusion gene EML4-ALK was identified in non-small cell lung carcinoma, which could be a potential therapeutic target. We investigated the prevalence of anaplastic lymphoma kinase protein expression in these tumors by immunohistochemistry and correlated the results with data from ALK molecular studies. Gene expression profiling was performed on 35 adenocarcinomas to identify cases with ALK gene up-regulation, which was correlated with protein overexpression by immunohistochemistry. Immunohistochemistry was also performed on an independent cohort consisting of 150 adenocarcinomas and 150 squamous cell carcinomas to evaluate the utility of anaplastic lymphoma kinase immunostaining as a screening tool. Florescence in situ hybridization for the ALK locus and reverse transcriptase-polymerase chain reaction for EML4-ALK were performed on tumors positive for anaplastic lymphoma kinase by immunohistochemistry. Transcriptional up-regulation of ALK was identified in 2 (6%) of 35 adenocarcinomas by gene expression profiling. These 2 cases were positive for anaplastic lymphoma kinase by immunohistochemistry, whereas the remaining 33 cases were completely negative. In the independent cohort, anaplastic lymphoma kinase immunostaining was positive in 1 of 150 squamous cell carcinomas and in 3 of 150 adenocarcinomas. The 6 cases positive for anaplastic lymphoma kinase by immunohistochemistry showed evidence of ALK locus rearrangement by florescence in situ hybridization but were negative for EGFR and KRAS mutation. The presence of EML4-ALK fusion transcript was confirmed in 2 cases by reverse transcriptase-polymerase chain reaction. In conclusion, anaplastic lymphoma kinase immunoreactivity in non-small cell lung carcinomas was associated with transcriptional up-regulation, ALK locus rearrangement, and the presence of EML4-ALK fusion transcript. Anaplastic lymphoma kinase immunohistochemistry may have utility as a screening tool or as a surrogate marker for the molecular techniques to detect the EML4-ALK fusion gene in these tumors.",

keywords = "ALK, EML4-ALK fusion transcript, FISH, NSCLC",

author = "Boland, {Jennifer M.} and Sibel Erdogan and George Vasmatzis and Ping Yang and Tillmans, {Lori S.} and Johnson, {Michele R.Erickson} and Xiaoke Wang and Peterson, {Lisa M.} and Halling, {Kevin C.} and Oliveira, {Andre M.} and Aubry, {Marie Christine} and Yi, {Eunhee S.}",

year = "2009",

month = aug,

doi = "10.1016/j.humpath.2009.01.012",

language = "English (US)",

volume = "40",

pages = "1152--1158",

journal = "Human Pathology",

issn = "0046-8177",

publisher = "W.B. Saunders Ltd",

number = "8",

}

TY - JOUR

T1 - Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas

AU - Boland, Jennifer M.

AU - Erdogan, Sibel

AU - Vasmatzis, George

AU - Yang, Ping

AU - Tillmans, Lori S.

AU - Johnson, Michele R.Erickson

AU - Wang, Xiaoke

AU - Peterson, Lisa M.

AU - Halling, Kevin C.

AU - Oliveira, Andre M.

AU - Aubry, Marie Christine

AU - Yi, Eunhee S.

PY - 2009/8

Y1 - 2009/8

N2 - Recently, the fusion gene EML4-ALK was identified in non-small cell lung carcinoma, which could be a potential therapeutic target. We investigated the prevalence of anaplastic lymphoma kinase protein expression in these tumors by immunohistochemistry and correlated the results with data from ALK molecular studies. Gene expression profiling was performed on 35 adenocarcinomas to identify cases with ALK gene up-regulation, which was correlated with protein overexpression by immunohistochemistry. Immunohistochemistry was also performed on an independent cohort consisting of 150 adenocarcinomas and 150 squamous cell carcinomas to evaluate the utility of anaplastic lymphoma kinase immunostaining as a screening tool. Florescence in situ hybridization for the ALK locus and reverse transcriptase-polymerase chain reaction for EML4-ALK were performed on tumors positive for anaplastic lymphoma kinase by immunohistochemistry. Transcriptional up-regulation of ALK was identified in 2 (6%) of 35 adenocarcinomas by gene expression profiling. These 2 cases were positive for anaplastic lymphoma kinase by immunohistochemistry, whereas the remaining 33 cases were completely negative. In the independent cohort, anaplastic lymphoma kinase immunostaining was positive in 1 of 150 squamous cell carcinomas and in 3 of 150 adenocarcinomas. The 6 cases positive for anaplastic lymphoma kinase by immunohistochemistry showed evidence of ALK locus rearrangement by florescence in situ hybridization but were negative for EGFR and KRAS mutation. The presence of EML4-ALK fusion transcript was confirmed in 2 cases by reverse transcriptase-polymerase chain reaction. In conclusion, anaplastic lymphoma kinase immunoreactivity in non-small cell lung carcinomas was associated with transcriptional up-regulation, ALK locus rearrangement, and the presence of EML4-ALK fusion transcript. Anaplastic lymphoma kinase immunohistochemistry may have utility as a screening tool or as a surrogate marker for the molecular techniques to detect the EML4-ALK fusion gene in these tumors.

AB - Recently, the fusion gene EML4-ALK was identified in non-small cell lung carcinoma, which could be a potential therapeutic target. We investigated the prevalence of anaplastic lymphoma kinase protein expression in these tumors by immunohistochemistry and correlated the results with data from ALK molecular studies. Gene expression profiling was performed on 35 adenocarcinomas to identify cases with ALK gene up-regulation, which was correlated with protein overexpression by immunohistochemistry. Immunohistochemistry was also performed on an independent cohort consisting of 150 adenocarcinomas and 150 squamous cell carcinomas to evaluate the utility of anaplastic lymphoma kinase immunostaining as a screening tool. Florescence in situ hybridization for the ALK locus and reverse transcriptase-polymerase chain reaction for EML4-ALK were performed on tumors positive for anaplastic lymphoma kinase by immunohistochemistry. Transcriptional up-regulation of ALK was identified in 2 (6%) of 35 adenocarcinomas by gene expression profiling. These 2 cases were positive for anaplastic lymphoma kinase by immunohistochemistry, whereas the remaining 33 cases were completely negative. In the independent cohort, anaplastic lymphoma kinase immunostaining was positive in 1 of 150 squamous cell carcinomas and in 3 of 150 adenocarcinomas. The 6 cases positive for anaplastic lymphoma kinase by immunohistochemistry showed evidence of ALK locus rearrangement by florescence in situ hybridization but were negative for EGFR and KRAS mutation. The presence of EML4-ALK fusion transcript was confirmed in 2 cases by reverse transcriptase-polymerase chain reaction. In conclusion, anaplastic lymphoma kinase immunoreactivity in non-small cell lung carcinomas was associated with transcriptional up-regulation, ALK locus rearrangement, and the presence of EML4-ALK fusion transcript. Anaplastic lymphoma kinase immunohistochemistry may have utility as a screening tool or as a surrogate marker for the molecular techniques to detect the EML4-ALK fusion gene in these tumors.

KW - ALK

KW - EML4-ALK fusion transcript

KW - FISH

KW - NSCLC

UR - http://www.scopus.com/inward/record.url?scp=67650441507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650441507&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2009.01.012

DO - 10.1016/j.humpath.2009.01.012

M3 - Article

C2 - 19386350

AN - SCOPUS:67650441507

SN - 0046-8177

VL - 40

SP - 1152

EP - 1158

JO - Human Pathology

JF - Human Pathology

IS - 8

ER -

Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this